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Abstract 
Purpose: To identify new antifungal lead compounds based on amphotericin B (AmB) molecular 
architecture.  
Methods: The strategy employed was molecular similarity search and screening based on the 
molecular constraints of polyene macrolide antibiotics, as well as docking experiments. Several new 
compounds were analyzed for their general inhibitory effect against indicator microbial strains. 
Interaction of the antifungal compounds with ergosterol and cholesterol was studied by UV-Vis 
spectroscopy and their effect on lipid/polydiacetylene (PDA) vesicles identified. Furthermore, the 
cytotoxicity of the compounds was evaluated and compared with that of amphotericin B. 
Results: In silico screening of 20,000 compounds obtained from the similarity search yielded seven 
candidates for in vitro antifungal test. The MIC of the more effective compounds, delta-decalactone and 
mandelonitrile, against three fungi - Candida albicans, Saccharomyces cerevisiae and Aspergillus niger 
- was in the range of < 46.8 to 750.0 µg/ml. By comparing peak position shifts for the absorbance of 
mandelonitrile and delta-decalactone individually and in combination with sterols, it was found that 
mandelonitrile has a more selective interaction with ergosterol. The color change intensity of lipid/PDA 
vesicles indicated that delta-decalactone potently disturbed simulated memberane structure. 
Furthermore, cytotoxicity data for mandelonitrile and delta-decalactone on HepG2 and MCF7 show that 
mandelonitrile is less cytotoxic, with IC50 of 1095.04 and 2010.34 µg/ml, and more selective against 
fungal cells. 
Conclusion: This study presents a new insight into algorithmic discovery of novel antifungal agents by 
in silico methodology based on a mechanistic approach. 
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Systemic infections have increased dramatically 
in the last few decades and they remain a major 
direct cause of death in patients being treated for 
malignant diseases and emerging immune 
deficiency diseases [1]. Management of fungal 
infections is notably limited by problems of drug 
safety, resistance and effectiveness drug forms 
[2].  
 
Current therapy for invasive mycoses uses a 
relatively reduced number of antifungal drugs 
that belong to three major groups: polyenes, 
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azoles and pyrimidines. The polyene antibiotics 
are among the most important ones and are 
produced by several different species of 
Streptomyces. The structure of these drugs 
consists of a lactone ring (20 - 24 carbons). The 
ring contains a series of conjugated double 
bonds (n = 3 - 8) which often have a glycoside 
residue.  
 
The target for the biological actions of these 
antibiotics are related to the cell membrane 
steroles [3]. AmB, one of these polyene 
antibiotics used to treat systemic fungal 
infections, forms membrane channels in fungal 
cells. These channels are thought to be made 
from antibiotic/sterol and are responsible for the 
leakage of ions, which cause cell destruction [4]. 
The chemotherapeutic use of AmB is based on 
its higher affinity for ergosterol (principal sterol in 
fungal cell membrane) than cholesterol (principal 
sterol in mammalian cell membrane). Since AmB 
also has a high affinity for cholesterol-containing 
membranes, it is quite toxic and its application in 
clinical treatment is limited to rather severe 
cases. AmB exhibits several crucial positive 
features as an effective antifungal drug, such as 
high antifungal activity, broad antifungal 
spectrum and very rare induction of fungal 
resistance as well as the ability to overcome 
multidrug-resistant fungi [5].  
 
Rational Drug Design (RDD) helps to facilitate 
and speed up the drug design process, which 
involves a variety of methods to identify novel 
compounds. One of these methods is virtual 
screening which is increasingly used as a cost-
effective complement to high-throughput 
screening [6]. There are two principal types of 
virtual screening system: 1) structure-based 
approaches, such as docking, which allows the 
scientist to virtually screen a database of 
compounds by fitting two molecules together in 
3D space for predicting the strongest binding 
based on various score functions; and 2) ligand-
based approaches, such as descriptor matrices 
and similarity methods. Similarity methods have 
been underdeveloped for decades are based on 
Similar Structure-Property Principle that states 
the molecules which are structurally similar and 
are likely to have similar properties. In 2D 
fingerprints, an attempt is made to map one 
molecule onto another; this means treating 
molecules A and B as graphs and finding any 
association between atoms in A and B [7,8]. 
 
In this context, the purpose of the present work 
was to find new antifungal lead compounds by 




In silico methods 
 
The focus was on screening of biological 
databases such as Enhanced NCBI database, 
Chemical Biology Laboratory (CBL, NCI, NIH), 
Pubchem (National Center for Biotechnology 
Information, Bethesda, United States), 
ChemIDplus (National Institutes of Health, 
Bethesda, Maryland, United States) and 
ChemBank-welcom (Broad Institute of Harvard & 
MIT/Chemical Biology Program, Cambridge, 
United States), by utilizing 2D fingerprints to 
compute a measure of molecular similarity 
between AmB, as a known reference structure, 
and each of the molecules in these databases. 
The 2D fingerprints encode the presence or 
absence of substructural fragments for the 
measurement [9]. Three similarity coefficients; 
Tversky, Euclidian and Tanimoto (> 70 %) were 
used to study the 2D fingerprint-based similarity. 
Among the molecules obtained from similarity 
search, the small molecules which had less 
molecular complexity than AmB were selected to 
dock, as ligands, with ergosterol and cholesterol, 
as receptors. Docking various ligands to the 
target of interest was followed by scoring to 
determine the affinity of binding and the strength 
of interactions. In general, it is important to 
visualize the docked poses of high-scoring 
compounds because many ligands are docked in 
different orientations and may often miss 
interactions that are known to be important for 
the target receptor [10].  
 
The docking analysis of the selected compounds 
were evaluated by Hex applicatoin (version 5.1, 
2008, LORIA, France). Default parameters were 
selected to obtain the best binding energy per 
ligand-receptor. SDfiles (.sdf) of receptors and 
ligands were converted to PDB (Protein Data 
Bank) format with MarvinSketch (version 5.0.4, 
ChemAxon, Budapest, Hungary) application 
software. Due to the large amount of the selected 
compounds, besides the docking expriments, an 
alternative approach to eliminate unpromising 
compounds was established. Hence, about 60 
polyene macrolid antibiotics, which form pores in 
the membrane, were gathered from literature 
[11]. Several physicochemical properties such as 
“logP, H-bond acceptor, H-bond donor, rotatable 
bond count and topological polar surface area”, 
which are important in drug design process, were 
gained from system (http://pubchem.ncbi.nlm. 
nih.gov/search/) to create a scoring system for 
filtering the selected compounds. Also, the 
mentioned properties for the selected 
compounds were measured in the same way as 
the polyene macrolid antibiotics. A datafile of the 
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docking results and physicochemical properties 
of the selected compounds were prepared. Using 
these data, the compounds that had the nearest 
interaction energy values with ergosterol in 
connection to AmB and also more similar 
properties to the computed ranges of the polyene 
macrolide antibiotics were selected. As many 
novel compounds, that could be found, were 
purchased for assay of their antifungal, simulated 
membrane activity and cytotoxic activities. 
 
In vitro methods 
 
Antifungal activity assay 
 
The antifungal activity of the purchased 
compounds were examined on three strains, viz, 
C. albicans (ATCC10231), S. cerevisiae (PTCC 
5052) and A.niger (A420), using broth 
microdilution assay. The broth microdilution 
method was performed according to NCCLS’ 
proposed guidelines [12]. All strains were sub-
cultured on Sabouraud maltose agar medium 
(SMA, Merck, Germany). C. albicans and S. 
cerevisiae were suspended in sterile 0.9 % NaCl 
solution; to make the inoculum of A.niger, the 
spores were dispersed in 0.1 % solution of 
Tween 20 (Merck, Germany). The turbidity of the 
suspensions of C. albicans, S. cerevisiae (75 – 
77 % )  and A. niger ( 80 – 82 % ) were adjusted 
using a spectrophotometer (Cecil, CE1021, 
Germany) at 530 nm. All inoculum suspensions 
were diluted (1:1000 for yeast and 1:50 for 
filamentous organisms) in Sabouraud maltose 
broth medium to obtain the final test inoculum.  
 
All the test compounds, namely, AmB, 
mandelonitrile, retinyl acetate, delta-decalactone, 
ergocalciferol (Sigma, Germany) and 2-
aminophenyl B-D-glucuronide hydrochloride 
(Carbosynth, Compton Berkshire UK), were 
dissolved in dimethyl sulfoxide (DMSO, Sigma, 
Germany) but amygdalin and retinyl palmitate 
(Sigma, Germany) were dissolved in water and 
aceton respectively. The concentrations of these 
compounds and AmB (positive control) were 10 
mg/ml and 3.2 mg/ml, respectively. Serial dilution 
of these stock solutions were prepared with SMB 
into microdilution wells. The diluted suspensions 
(100 μl) were added to 100 μl of the diluted 
solutions to obtain the desired concentrations for 
the experiment. The final test samples of the 
compounds and amphotericin B were diluted, 
from 1000 to 1.9 and 32 to 0.06 μg/ml, 
respectively, by addition of culture media and 
diluted microbial suspensions to all the wells. 
Microdilution trays were incubated at 35 °C and 
examined after 48 h to determine MIC (minimum 
inhibitory concentration) values. 
 
Study of interactions in solution  
 
Among the test compounds, mandelonitrile and 
delta-decalactone show moderate antifungal 
activity, and so the interaction (in solution) of 
these compounds with ergosterol and cholesterol 
(Sigma, Germany) were studied by UV-Vis 
spectroscopy. Mandelonitrile, delta-decalactone 
and AmB (as positive control) were dissolved 
separately in DMSO and diluted with water to 
obtain 50-µM stock solutions; they were always 
freshly prepared the same day they were used. 
The final concentration of DMSO in the stock 
solutions was 1 % v/v. The sterols were 
solubilized in n-propanol (Sigma, Germany). The 
samples used were prepared from the stock 
solutions by adding the required quantity of sterol 
solution. The final concentration of these 
compounds was set at 6.5 µM and the solution 
contained 6.5 %v/v of n-propanol [13]. This 
concentration for AmB was chosen because it 
represents the concentration of AmB in 
circulation in the blood after administration. It has 
been observed that in sterols:AmB molar ratio of 
5:1, the selectivity of interaction of AmB with 
ergosterol and cholesterol is increased [14]. 
Therefore, this concentration and molar ratio 
were selected for the preparation of 
mandelonitrile and delta-decalactone solutions. 
UV-Vis spectra were recorded within 30 min of 
their preparation, and the absorbance against a 
6.5 % v/v solution of n-propanol in water was 
taken using a NanoDrop 1000 spectrophoto-
meter (Thermo Scientific, USA) in the region of 
300-750 nm. This solvent was used to ensure 
proper solubility of the sterols and, it has been 
shown that at this concentration, n-propanol has 
no effect on interactions of the antibiotic with the 
sterols.  
 
Membrane interaction study  
 
In order to determine the effect of mandelonitrile 
and delta-decalactone on lipid membrane, 
phospholipid/PDA vesicles were used as a 
membrane module. Polydiacetylene polymers 
have some important characteristics such as 
blue-red color transition under external 
perturbation that can be visible by the naked eye. 
To prepare polymerized vesicles, the stock 
solutions (1 mg/ml)  of dimyristoylphosphati-
dylcholine (DMPC, Sigma, USA), and the 
diacetylenic monomer, 10,12-tricocosadiynoic 
acid (TCDA, Sigma, USA), were prepared in 
dichloromethane. A working solution comprising 
DMPC- TCDA (40:60, v/v) was obtained perior to 
use. The tube was dried under nitrogen. The 
residue was dissolved in 1ml deionized water  by 
bath sonicator for 8-9 min. The final solution was 
kept at 4 0C overnight and when needed, final 
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solution polymerized by  UV irradiation at 254 nm 
for 60 s, resulting in intense blue color 
appearance due to polymerization of the 
diacetylene units [15]. Mandelonitrile, delta-
decalactone and AmB (positive control) were 
dissolved in DMSO and diluted with water. The 
molar ratio of the compound/vesicle solutions 
were kept the same and the final concentrations 
were similar to that used for UV-Vis spectroscopy 
experiments.  
 
In vitro toxicity study 
  
HepG2 (Human hepatocellular liver carcinoma) 
and MCF7 (Human breast adenocarcinoma) cell 
lines were obtained from National Cell Bank of 
Pasture Institute of Iran. The cells were grown in 
Roswell Park Memorial Institute (RPMI) 1640, 
culture medium (Gibco, Grand Island, NY) 
supplemented with fetal bovine serum 10 % 
(FBS, Gibco, Grand Island, NY) and incubated 
for 3 days at 37 °C in a humidified 5 % CO2 
atmosphere.  
 
In vitro cytoxicity of mandelonitrile and delta-
decalactone were evaluated by MTT ([3-(4, 5-
dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium 
bromide]) assay. Harvested cells with trypsin 
(0.25 %, Sigma, Germany) were counted by 
Neubauer slide. The cells were seeded into 96-
well plates in RPMI, 10 % FBS (104 cells in 100 
μl per well) and incubated for 48 h. Thereafter, 
the medium was replaced with 100 µl of various 
dilutions of the test compounds. In the first step, 
the stock solutions of the compounds were 
prepared in DMSO and sterilized using 
membrane filters of 0.45µm pore size [16]. 
Different concentrations of the stock solutions 
were prapared by serial dilution using RPMI, 10 
% FBS. Mandelonitrile and delta-decalactone (in 
750, 375, 187 and 93 µg/ml concentrations) and 
AmB (positive control, in 2, 1, 0.5 and 0.025 
µg/ml concentrations) were prepared. DMSO 
solution was applied as solvent control in 
concentrations ranging from 1 to 0.12 %. The 
plates were incubated for 24 h at 37 °C in a 
humidified 5 % CO2 chamber. A single dose of 
each compound was evaluated in triplicate in the 
cytotoxicity assay. Following, the incubation 
period, 0.01 ml of MTT solution, (Sigma, 
Germany) at a final concentration of 5 mg/ml in 
phosphate-buffered saline (PBS, Sigma, 
Germany) was added per well. The plates were 
then incubated for an additional period of 3 - 5 h 
at 37 °C. Thereafter, the culture medium 
including MTT solution in each well, was 
removed, 150 μl of DMSO was added to each 
well and then mixed to dissolve the blue 
formazan crystals. The absorbance of the 
samples was immediately read at 570 nm using 
a 96-well plate reader (ELISA reader, Organon 
Tekninka, Netherlands). Cytotoxicity (%) was 
calculated according to Eqs 1 and 2. 
 
Viability (%) = (At/Au)100 ………………. (1) 
 




The 50 % inhibition concentration (IC50) values of 
mandelonitrile and delta-decalactone on MCF-7 
and HepG2 cells at 24 h were determined by 
probit analysis using the GraphPad Instat 
(DATASET1.ISD) software. To determine the 
cytotoxic effect of test compounds, paired t-test 




In silico results 
 
Approximately 20,000 compounds were obtained 
from AmB structural similarity search. In total, a 
subset of about 400 compounds, which had less 
molecular complexity compared with AmB, were 
selected for further screening by docking 
experiments and molecular constraints (property 
based search). It has been shown that AmB does 
not only target ergosterol as a receptor in the 
fungal cell membrane, but also has less affinity 
towards cholesterol in mammalian cell 
membrane. Therefore, the selected compounds 
were docked onto the target receptors, i.e., 
ergosterol and cholesterol by Hex application 
and were evaluated for the binding compatibility 
to these receptors based on docked energy. The 
docking tool generated 100 poses for each 
docked pair of molecules. AmB on docking with 
ergosterol and cholesterol produced an energy 
value of -186.0 and -170.9 kcal/mol, respectively. 
Depending on the docked energy values and 
property filter approach, a library of 40 specific 
and diverse ligand candidates was formed. 
Ultimately, seven of these compounds were 
commercially available. The structures of these 




The MIC values of the test compounds against 
the test fungal strains are presented in Table 1. 
The MICs of delta-decalactone and mandelo-





UV-Vis spectroscopy was used to study the 
interactions in solution between the antifungal  
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Figure 1: Structure of compounds that were obtained by virtual screening: a = ergocalciferol; b = retinyl 
palmitate; c = retinyl acetate; d = delta-decalactone; e = 2-aminophenyl glucuronide; f = amygdalin; g = 
mandelonitrile 
 
Table 1: In vitro activity (MIC) of test compounds 
against two strains of yeasts and one strain of 









AmB 0.5-1.0 0.25-0.50 2.0-4.0 
Ergocalciferol N.I. N.I. N.I. 
Retinyl acetate N.I. N.I. N.I. 
Retinyl palmitate N.I. N.I. N.I. 
Delta-
decalactone 93.7 < 46.8 187.5 
Mandelonitrile 750 187.5 750 
Amygdalin N.I. N.I. N.I. 
2 -Aminophenyl 
glucuronide 1000 1000 2000 
N.I =  No Inhibition up to the highest test concentration 
 
compounds and the sterols. The interactions 
resulted in different spectra on the basis of the 
difference in their structures. Ergosterol has an 
additional double bond at position 7 in the 
molecule, compared to cholesterol, and an 
additional methyl and double bond on the side 
chain that makes it susceptible to maximum 
hydrophobic interactions (compared to 
cholesterol). [13].  
 
The spectra recorded for AmB (reference) alone 
shows 4 specific bands in the regions of 335, 
364, 368 and 409 nm. The interactions between 
AmB and the sterols could be followed through a 
shift in absorbance intensity and wavelength. 
When AmB was mixed with sterols, the spectra 
shifted to the right (red shift) and showed 4 
specific bands approximately in the following 
regions: 353, 367, 388 and 415 nm. The band at 
415 nm has been identified in the literature as 
characteristic of AmB interaction with the sterols 
[13]. The absorbance intensity of AmB mixed 
with ergosterol is higher than that for cholesterol. 
The spectra of either mandelonitrile alone, or 
mixed with cholesterol, does not present any 
specific band in the region 220 - 750 nm; 
however, the spectra of mandelonitrile mixed 
with ergosterol presents two additional bands, 
compared with ergosterol alone. It indicates that 
cholesterol, unlike ergosterol, did not noticeably 
interact with mandelonitrile. Also, the spectra of 
delta-decalactone alone did not show any 
specific band in this region, but the spectra 
recorded for delta-decalactone mixed with sterols 
indicate three bands in the regions 271, 283 and 
298 nm that have near identical absorbance. 
They, therefore, may have the same tendency 
towards these sterols. The absorbance values 
obtained at these wavelengths are shown in 
Table 2. 
 
Membrane activity  
 
 Lipid/PDA vesicles were used to study the 
impact of the antifungal compounds on simulated 
lipid membrane. By interacting tested 
compounds with vesicles and disrupting them, 
blue-red color transition can be recognized with 
the naked eye [15]. As shown in Figure 2, the 
color change intensity of delta-decalactone was 
greater than that of AmB (positive control) and 
mandelonitrile. This means that delta-
decalactone was more potent on lipids of 
membrane simulated vesicles.  
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Table 2: The regions of the specific bands for the UV-Vis spectra of antifungal compounds individually and in 
combination with sterols 
 
Band IV  Band III  Band II  Band I  
A  λ   A  λ   A  λ   A  λ  
Compounds  
0.017  409  0.022  386  0.023  364  0.04  335  AmB  
--- --- --- --- --- --- --- --- Cholesterol 
--- --- --- --- 0.024 276 0.023 262 Ergosterol 
--- --- --- --- --- --- --- --- Mandelonitrile 
---  ---  ---  ---  ---  ---  ---  ---  Delta-decalactone 
0.031  415  0.043  388  0.052  367  0.038  353  AmB:Ergosterol  
0.017  415  0.024  388  0.035  367  0.019  353  AmB:Cholesterol  
0.025  296  0.032  283  0.035  273  0.031  262  Mandelonitrile:Ergosterol  
--- --- --- --- --- --- --- --- Mandelonitrile:Cholesterol 
---  ---  0.016  298  0.023  283  0.027  271  Delta-decalactone:Ergosterol 
---  ---  0.022  298  0.029  283  0.035  271  Delta-decalactone:Cholesterol 














Figure 2: Color changes produced by interaction of lipid vesicles with test antifungal compounds 
after adding (a) deionized water (control solution); (b) DMSO (control solvent); (c) mandelonitrile; 
(d) delta-decalactone; (e) AmB (positive control) 
 
Cytotoxicity of antifungal compounds 
 
Both cell lines (HepG2 and MCF7) showed 
nearly the same pattern of dose-dependent 
responses in the presence of each test 
compound. The concentrations of AmB, delta-
decalactone and mandelonitrile that inhibited 50 
% growth of cell lines (IC50) are shown in Table 
3. To determine if the cytotoxic effect of the 
solvent those of test compounds, paired t-test (p 
< 0.05) was applied to the data and the results 
(Table 4) show that cytotoxic activity of all the 
test compounds on the two cell lines was 
independent of that of the solvent, DMSO.  
 
Table 3: Cytotoxic activity of the test antifungal 
compounds on two cancer cell lines 
 
IC50 (µg/ml) Cell 
line AmB Mandelonitrile Delta-decalactone 
HepG2 2.06 1095.04 750.79 
MCF7 4.96 2010.34 1601.48 
 
Table 4: P-value to determine whether cytotoxic 
activity of the test antifungal compounds was 
influenced by that of the solvent (DMSO) 
 
P-value ( p < 0.05)*  
Cell 
line 
Am B Mandelonitrile Delta-
decalactone 
HepG2 0.0016 0.0006 0.0258 
MCF7 0.0051 0.0003 0.0212 
*P-value was calculated by GraphPad Instat (version 




There is still a need to develop suitable 
antifungal lead compounds for the drug 
development pipeline. Similarity lead finding 
studies using 2D fingerprints, which came into 
wide use in the late 1990s, is one of the simplest 
virtual screening tools and can be useful in the 
early stages of any lead-discovery project. Some 
advantages of this method include the fact that  
there is no need to know the active conformation 
of the query molecule, searching large databases 
18  
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can be routinely performed and this method is 
much more cost-effective than others [6].  
 
In this study, we proposed a combination of 
methods involving 2D similarity search, docking 
and filttering the similar compounds based on the 
molecular properties of the polyene macrolide 
antibiotics in order to reduce the dataset size to 
be finally selected. Based on the results 
obtained, two compounds were identified that 
may be worth studying further in terms of their 
antifungal activities, delta-decalactone and 
mandelonitrile, with the former more effective 
than the latter, but the activity of the latter was 
more targeted towards ergosterol. These 
differences may be due to differences between 
their structures.  
 
Mandelonitrile is naturally found in the millipede, 
Apheloria corrugate, as a defense weapon [17]. 
On the other hand, the special flavor of ripe 
peach is mainly due to lactones, especially delta-
decalactone. It is also present in apricot, Prunus 
armeniaca, and nectarine, Prunus persica var. 
nucipersica [18]. The skin of ripe nectarines 
smells powerfully of these lactones. It is applied 
in industry as a feed additive and flavoring agent 
It is important to note that the structures of these 
compounds are rather simpler than that of AmB. 
However, they both exhibit antifungal activitiy 
and a similar mode of antifungal action as AmB, 
based on the findings of the present study.  
 
The interactions of AmB with ergosterol and 
cholesterol have previously been studied [13]. It 
is also well-known that the UV-Vis spectrum of 
AmB in the region of 300-450 nm is very 
sensitive to the environment around the antibiotic 
molecule. One can also conclude that the affinity 
of AmB towards ergosterol is higher than 
cholesterol. The higher UV-Vis absorption 
demonstrated by delta-decalactone solution 
indicates that the compound has a lower affinity 
than mandelonitrile to ergosterol. However, 
mandelonitrile has almost no affinity towards 
cholesterol, which in general, translates to more 
selectivity towards ergosterol.  
 
The results for the lipid/PDA vesicles indicate 
that delta-decalactone disrupts the membrane’s 
phospholipids more actively. Since, 
mandelonitrile is less cytotoxic than delta-
decalactone on the selected cell lines, could the 
latter is likely to show lower adverse effects on 
mammalian cell membranes.  
 
In addition to the compounds tested in this study, 
other molecules present in the filtered subset 
structures, such as fumifungin and 
glucolanomycin, that have previously been 
reported as antifungal compounds. Fumifungin 
and glucolanomycin were isolated from Y-
83,0405 culture obtained from soil and 
fermentation liquids of Pycnidiophora dispersa, 
respectively [19,20]. The presence of such 
antifungal agents among the filtered library of 
compounds would further aid in the elucidation of 
the capacity of the screening algorithm applied in 




The in silico experimental data obtained in the 
present study indicate that the selection 
algorithm used is efficient and the process is less 
time-consuming and more cost-effective, and 
therefore can speed up the identification of 
suitable novel antifungal lead compounds. 
Furthermore, mandelonitrile and delta-
decalactone are suitable antifungal lead 
compounds that can be further developed to 
improve their potency, and thus, may find a 
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